BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31949094)

  • 1. Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis.
    Bunod R; Adams D; Cauquil C; Francou B; Labeyrie C; Bourenane H; Adam C; Algalarrondo V; Slama M; Darce-Bello M; Barreau E; Labetoulle M; Rousseau A
    Br J Ophthalmol; 2020 Oct; 104(10):1363-1367. PubMed ID: 31949094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation).
    Rousseau A; Terrada C; Touhami S; Barreau E; Rothschild PR; Valleix S; Benoudiba F; Errera MH; Cauquil C; Guiochon-Mantel A; Adams D; Labetoulle M
    Am J Ophthalmol; 2018 Aug; 192():169-177. PubMed ID: 29859145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
    Liu T; Zhang B; Jin X; Wang W; Lee J; Li J; Yuan H; Cheng X
    Eye (Lond); 2014 Jan; 28(1):26-33. PubMed ID: 24113303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposits on Retinal Surface Seen on OCT in Ocular Amyloidosis.
    Kakihara S; Hirano T; Matsuda Y; Takano D; Imai A; Miyahara T; Murata T
    Ophthalmol Retina; 2021 Oct; 5(10):1005-1008. PubMed ID: 33422693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
    Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
    Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
    Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AN 82-YEAR-OLD WOMAN WITH RETINAL VASCULAR SHEATHING AND VITREOUS HEMORRHAGE.
    Hudson JL; Schwartz SG; Davis JL
    Retin Cases Brief Rep; 2023 Jun; 17(4S):S36-S40. PubMed ID: 35993733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis - assessed with optical coherence tomography angiography.
    Marques JH; Coelho J; Malheiro J; Pessoa B; Beirão JM
    Amyloid; 2021 Mar; 28(1):66-71. PubMed ID: 32996337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphic and Echocardiographic Study of Patients with Pathogenic or Probably Pathogenic Variants of the TTR Gene without Overt Cardiac Involvement.
    Silva TO; Darzé ES; Costa MM; José Junior L; Ximenes AAB; Fernandes F; Rocha MS; Noya-Rabelo MM; Ritt LEF
    Arq Bras Cardiol; 2024; 121(4):e20230216. PubMed ID: 38775614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.
    Lv W; Chen J; Chen W; Hou P; Pang CP; Chen H
    Eye (Lond); 2014 Apr; 28(4):452-8. PubMed ID: 24480837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features.
    Dori A; Arad M; Wasserstrum Y; Pollak A; Nikitin V; Ben-David M; Shamash J; Nahum AH; Shavit-Stein E; Domachevsky L; Kuperstein R; Dominissini D; Shelestovich N; Sadeh M; Pras E; Greenbaum L
    Ann Clin Transl Neurol; 2023 Apr; 10(4):553-567. PubMed ID: 36772971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
    Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
    Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCULAR MANIFESTATIONS OF ASP38ALA AND THR59LYS FAMILIAL TRANSTHYRETIN AMYLOIDOSIS.
    Choi KJ; Son KY; Kang SW; Kim D; Choi JO; Kim HJ; Kim JS; Jeon ES; Kim AY; Kang MC; Kim SJ
    Retina; 2022 Feb; 42(2):396-403. PubMed ID: 34483316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
    Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
    Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy.
    Smiley DA; Einstein AJ; Mintz A; Shetty M; Chan N; Helmke ST; Bhatia K; Goldner K; Brannagan TH; Santana DD; Maurer MS
    Circ Cardiovasc Imaging; 2023 Aug; 16(8):e015243. PubMed ID: 37334703
    [No Abstract]   [Full Text] [Related]  

  • 17. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of optical coherence tomography angiography to assess systemic severity in patients with hereditary transthyretin amyloidosis.
    Kakihara S; Hirano T; Kitahara J; Matsuda Y; Imai A; Miyahara T; Murata T
    PLoS One; 2022; 17(9):e0275180. PubMed ID: 36156600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive
    Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K
    Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.